ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
美国抗疫概念
1,724.47
-30.1818
-1.72%
涨家数:
- -
跌家数:
19
平家数:
- -
市盈率:
- -
高:
1,756.44
开:
1,754.52
低:
1,720.39
收:
1,754.66
成交量:
3.00亿
成交额:
183.67亿
市值:
1.41万亿
流通市值:
1.39万亿
数据加载中...
总览
新闻资讯
阿斯利康苏博科:中国在技术发展领域处于领先地位
睿见Economy
·
5小时前
雅培公司董事长罗赋德:建议为创新产品提供3-5年的定价弹性期
睿见Economy
·
6小时前
清华大学与阿斯利康签署校级科研合作协议,加速新药研发进程
新京报
·
03/21
肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论
路透中文
·
03/21
肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论
路透中文
·
03/20
Co-Diagnostics签署协议,大幅扩张南亚地区商业与分销版图
美股速递
·
03/20
背景资料-过去几十年的大宗消费交易
路透中文
·
03/20
外资再加码!医药巨头阿斯利康核药生产供应基地落子黄埔
21世纪经济报道
·
03/19
吉利德科学(GILD.US)CD19/CD20 CAR-T细胞疗法启动III期临床
智通财经
·
03/19
阿斯利康将于广州建设放射性偶联药物生产供应基地
格隆汇
·
03/19
辉瑞:Talzenna联合Xtandi安全性符合各自已知安全特征,未发现新安全信号
美股速递
·
03/19
Talzenna联合Xtandi显著改善转移性前列腺癌患者的影像学无进展生存期
美股速递
·
03/19
落子上海细胞治疗全链条,阿斯利康“深耕中国”迈入新阶段
21世纪经济报道
·
03/19
阿斯利康宣布在上海建立细胞疗法商业化生产供应基地与创新中心
南方财经网
·
03/19
阿斯利康中国区副总裁黄彬突然离职
消费日报财经
·
03/19
再迎阿斯利康重磅布局!浦东生物医药产业究竟有啥“磁场效应”?
上观新闻
·
03/19
分析-TrumpRx 列出的许多药品价格高于在英国支付的价格
路透中文
·
03/19
BUZZ-艾伯维下跌,因强生银屑病药物增加竞争风险
路透中文
·
03/18
强生治疗银屑病的口服药物获美国FDA批准
格隆汇
·
03/18
辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点
智通财经
·
03/18
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1724.4738,"timestamp":1774036799999,"preClose":1754.6555,"halted":0,"volume":300102900,"delay":0,"changeRate":-0.017201,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-30.181763,"latestTime":"03-20 16:00:00 EDT","open":1754.5234,"high":1756.4438,"low":1720.3867,"amount":18367104552.24066,"amplitude":0.020549,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774272600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.409314,"peRate":25.738578,"turnoverRate":0.02166,"increases":0,"decrements":19,"flats":0,"marketCap":1406737421047.75,"floatMarketCap":1387116339250},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1756.4438,"amplitude":0.020549,"preClose":1754.6555,"low":1720.3867,"pbRate":"4.409314","latestPrice":1724.4738,"volume":300102900,"delay":0,"open":1754.5234,"prevYearClose":1637.1339,"prevWeekClose":1724.4738,"prevMonthClose":1860.0614,"prevQuarterClose":1637.1339,"fiveDayClose":1770.3531,"twentyDayClose":1820.3057,"sixtyDayClose":1643.4171,"secType":"PLATE","market":"US","turnoverRate":0.02166,"peRate":25.738578,"marketCap":1406737421047.75,"floatMarketCap":1387116339250,"timestamp":1774036799999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":0,"down":19,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621726134","title":"阿斯利康苏博科:中国在技术发展领域处于领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2621726134","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621726134?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 11:18","pubTimestamp":1774235880,"startTime":"0","endTime":"0","summary":" 中国发展高层论坛2026年年会于3月22日至23日在北京举行。在“健康中国2030”与大健康产业发展专题研讨会上,阿斯利康全球首席执行官苏博科强调,中国在技术发展领域处于领先地位,未来几年将在全球医疗健康行业发挥更重要作用:目前全球25%的临床试验在中国开展,30%的全球行业价值流向中国,而10年前这一比例仅为1%,充分彰显了中国在全球医疗领域的重要影响力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/meeting/2026-03-23/doc-inhrxvtx8052868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0109394709.USD","LU2417539215.USD","LU0889565916.HKD","BK4588","BK4007","LU0289739699.SGD","LU2456880835.USD","BK4585","BK4568","LU2462157665.USD","BRCD","LU0058720904.USD","LU0320765992.SGD","LU2236285917.USD","IE00B3T34201.USD","AZN","LU1829250122.USD"],"gpt_icon":0},{"id":"2621259857","title":"雅培公司董事长罗赋德:建议为创新产品提供3-5年的定价弹性期","url":"https://stock-news.laohu8.com/highlight/detail?id=2621259857","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621259857?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 10:41","pubTimestamp":1774233660,"startTime":"0","endTime":"0","summary":" 中国发展高层论坛2026年年会于3月22日至23日在北京举行。在“健康中国2030”与大健康产业发展专题研讨会上,雅培公司董事长、首席执行官罗赋德表示,进入中国38年来,雅培始终坚守“立足中国、服务中国、服务世界”的长期承诺,并持续深化这一理念。雅培设定的目标是到2030年每年助力改善30亿人的生活,相当于全球每3个人中就有1人受益,而中国是实现这一愿景的关键部分。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/meeting/2026-03-23/doc-inhrxvtw1243540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2089984988.USD","LU0114720955.EUR","LU1989763427.SGD","LU1691799644.USD","BK4592","LU2211815571.USD","LU0868494617.USD","ABT","BK4504","BK4588","BK4082","LU2237957811.SGD","BK4581","LU0170899867.USD","LU2468319806.SGD","IE0002141913.USD","SG9999002232.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU1057294990.SGD","LU0122379950.USD","LU1721429402.USD","IE00BJT1NW94.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","SGXZ41872573.SGD","LU0882574055.USD","LU1023059063.AUD","SG9999004303.SGD","BK4566","LU0289739699.SGD","LU1989763690.USD","LU0234572021.USD","BK4533","SGXZ23171101.USD","LU1721429741.USD","BK4568","LU2237957902.USD","LU1914381329.SGD","LU0058720904.USD","BK4585","IE00BFTCPJ56.SGD","LU0266013472.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2621762898","title":"清华大学与阿斯利康签署校级科研合作协议,加速新药研发进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2621762898","media":"新京报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621762898?lang=zh_cn&edition=fundamental","pubTime":"2026-03-21 16:48","pubTimestamp":1774082880,"startTime":"0","endTime":"0","summary":"新京报讯(记者王卡拉)3月20日,阿斯利康与清华大学正式签署校级科研合作协议,并宣布成立“清华大学(智能产业研究院)——阿斯利康人工智能药物研发联合研究中心”。该协议旨在建立阿斯利康与清华大学的长期战略合作关系,双方将重点围绕疾病机制研究、多组学分析与数据科学、生物标志物发现、转化医学、临床开发策略、人工智能应用等领域开展合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603213679602747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603213679602747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2236285917.USD","BK4588","LU0058720904.USD","LU0320765992.SGD","LU1829250122.USD","IE00B3T34201.USD","BK4007","BK4568","AZN","LU0889565916.HKD","LU0289739699.SGD","LU2456880835.USD","LU2417539215.USD","BK4585","LU0109394709.USD","LU2462157665.USD"],"gpt_icon":0},{"id":"2621755933","title":"肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论","url":"https://stock-news.laohu8.com/highlight/detail?id=2621755933","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621755933?lang=zh_cn&edition=fundamental","pubTime":"2026-03-21 01:59","pubTimestamp":1774029564,"startTime":"0","endTime":"0","summary":"更新版 1-肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论肯特郡疫情爆发后乙型脑膜炎疫苗需求激增药房报告疫苗短缺,政府向私人市场发放 20,000 剂 NHS 疫苗在公共卫生辩论中呼吁扩大青少年疫苗接种范围学生报告称等待接种疫苗的时间长达 8 小时第 5-6 段增加了接种疫苗的学生的评论Muvija M/Jennifer Rigby. 担心与肯特郡疫情中的患者有过接触的人可以通过大学校舍、诊所和家庭医生从英国卫生安全局获得疫苗和预防性抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T4081MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4592","IE00BBT3K403.USD","IE00B19Z3581.USD","BK5011","LU1400636491.USD","LU1481600234.SGD","LU0203345920.USD","IE0034235071.USD","LU1894683264.USD","LU0109981661.USD","LU1057294990.SGD","LU1228905037.USD","LU1400636657.SGD","LU1098665638.USD","SG9999001176.USD","LU1481599808.USD","SG9999001176.SGD","LU0971552830.HKD","LU1302929846.USD","BK4533","BK4588","LU0306806265.USD","LU1983299246.USD","LU1015430645.USD","BK4550","LU1064927863.SGD","BK4599","LU1046248800.SGD","SG9999011175.SGD","LU0170899867.USD","LU0306807586.USD","GSK.UK","LU0289739699.SGD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4568","IE00BWDBJ516.SGD","LU1066053197.SGD","IE00B3T34201.USD","LU0122379950.USD","LU0545562505.USD","LU0971552673.USD","LU1670756490.USD","LU0211331839.USD","SG9999013999.USD","LU0321505868.SGD","BK4581","LU1400636574.HKD","LU0161305163.EUR","LU1035777561.USD","LU1202635105.USD","LU0456855351.SGD","BK4534","LU0234572021.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU0868494617.USD","LU1066051498.USD","IE0002270589.USD","SG9999003800.SGD","LU1309081286.SGD","LU1487256676.USD","LU1228905540.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4007","BK4585","LU0058720904.USD","LU0225771236.USD","LU0203347892.USD","IE000M9KFDE8.USD","LU0321505439.SGD","IE00BQJZX424.USD","LU0575583348.USD","LU1645745479.HKD","LU1883839398.USD","LU0225284248.USD","SG9999002232.USD"],"gpt_icon":0},{"id":"2620734824","title":"肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论","url":"https://stock-news.laohu8.com/highlight/detail?id=2620734824","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620734824?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 21:58","pubTimestamp":1774015082,"startTime":"0","endTime":"0","summary":"肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论肯特郡疫情爆发后乙型脑膜炎疫苗需求激增药房报告疫苗短缺,政府向私人市场发放 20,000 剂 NHS 疫苗在公共卫生辩论中呼吁扩大青少年疫苗接种范围Muvija M/Jennifer Rigby. 担心与肯特郡疫情中的患者有过接触的人可以通过大学校舍、诊所和全科医生从英国卫生安全局获得疫苗和预防性抗生素。自 2015 年以来,乙型脑膜炎疫苗一直注射给婴儿,他们是该疾病的高危人群,而针对其他菌株的不同疫苗则注射给青少年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T408188:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0321505868.SGD","SG9999003800.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4007","LU1983299246.USD","IE00B3T34201.USD","LU0321505439.SGD","LU0122379950.USD","LU1035777561.USD","LU1066053197.SGD","LU0306806265.USD","LU1046248800.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0203347892.USD","IE00BBT3K403.USD","LU0971552673.USD","LU0058720904.USD","LU1670756490.USD","LU1202635105.USD","IE00BLSP4239.USD","BK5011","GSK","LU0161305163.EUR","LU0306807586.USD","LU0203345920.USD","LU0575583348.USD","LU0211331839.USD","IE00BQJZX424.USD","IE0034235071.USD","LU0545562505.USD","LU1400636491.USD","IE0002270589.USD","LU0985481810.HKD","LU1309081286.SGD","IE00BWDBJ516.SGD","BK4581","LU0289739699.SGD","LU1098665638.USD","LU1228905037.USD","LU1645745479.HKD","BK4568","LU1400636574.HKD","LU1481599808.USD","LU1400636657.SGD","SG9999002232.USD","BK4550","LU1057294990.SGD","SG9999001176.SGD","LU0868494617.USD","BK4534","BK4588","BK4592","LU1894683348.USD","LU1487256676.USD","BK4599","LU0225771236.USD","LU1228905540.USD","LU0109981661.USD","SG9999013999.USD","SG9999011175.SGD","LU0170899867.USD","LU1015430645.USD","LU1302929846.USD","BK4533","SG9999001176.USD","LU1066051498.USD","LU1481600234.SGD","LU0456855351.SGD","LU1894683264.USD","LU0971552830.HKD","LU0225284248.USD","BK4585","LU1064927863.SGD","LU1883839398.USD"],"gpt_icon":0},{"id":"1164912675","title":"Co-Diagnostics签署协议,大幅扩张南亚地区商业与分销版图","url":"https://stock-news.laohu8.com/highlight/detail?id=1164912675","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164912675?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 20:00","pubTimestamp":1774008014,"startTime":"0","endTime":"0","summary":"Co-Diagnostics, Inc. (CODX) 已签署一项关键协议,旨在将其商业运营与产品分销网络广泛覆盖至南亚地区。此举标志着该公司在全球市场,尤其是在亚洲新兴经济体中的战略布局取得重大进展。通过本次合作,Co-Diagnostics有望显著提升其诊断产品在该区域的可及性与市场渗透率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2620805757","title":"背景资料-过去几十年的大宗消费交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2620805757","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620805757?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 19:00","pubTimestamp":1774004432,"startTime":"0","endTime":"0","summary":"联合利华正在洽谈将其食品业务出售给规模较小的竞争对手麦考密克,这项潜在的交易将把这家英国公司的赫尔曼和康宝品牌与这家美国调味品制造商的乔鲁拉辣酱联合起来。2010 年 1 月 19 日 根据汤森路透的数据,卡夫食品公司以约 196 亿美元的价格收购了 英国糖果制造商吉百利,从而成为全球最大的糖果制造商,这也是有史以来欧洲最大的食品饮料交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T4080U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989763427.SGD","LU0971552673.USD","LU0997586606.USD","SG9999013999.USD","LU0889565080.SGD","LU1244550221.USD","LU0731783394.SGD","LU2463526074.USD","IE00BLSP4239.USD","SG9999001440.SGD","LU0251131958.USD","LU0690374961.EUR","LU2242646821.SGD","LU1046421449.USD","IE00BVYPNW00.USD","LU0170899867.USD","LU1814569148.SGD","LU1244550494.USD","LU1699723380.USD","LU0553294199.USD","LU0128525929.USD","LU1023061713.HKD","LU0648001328.SGD","LU1201861249.SGD","LU0997587240.USD","LU0345770308.USD","LU0011850046.USD","LU1670756490.USD","LU2404859667.USD","LU1023061473.USD","BK4504","LU0985489474.SGD","LU1400636657.SGD","LU0171281750.USD","LU0345777659.USD","LU0312595415.SGD","LU2491050154.USD","SG9999002224.SGD","LU1481600234.SGD","03165","LU1489326972.SGD","LU0738911758.USD","BK4566","IE00BYV24P56.USD","SGXZ57979304.SGD","LU0048573561.USD","LU0320765489.SGD","LU1571399168.USD","GB00B4QBRK32.GBP","LU0310800965.SGD","LU0289739699.SGD","BK4599","IE00BVYPNV92.GBP","LU0130102774.USD","LU0964806797.USD","LU0980610538.SGD","LU1599440770.SGD","LU1046248800.SGD","LU1929549753.HKD","LU1863844749.USD","LU1280957306.USD","LU2404859741.USD","LU0215105999.USD","LU0058720904.USD","IE00BJTD4V19.USD","LU0708994859.HKD","LU2089284900.SGD","LU0345777147.USD","LU0772969993.USD","LU0321505439.SGD","LU0545039389.USD","LU0690374615.EUR","LU1003077747.HKD","LU1400636574.HKD","BK4585","BK4567","LU2491050071.SGD","LU1509826696.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU0640476718.USD","LU0575583348.USD","LU0302445910.USD","LU0208291251.USD","LU0889566641.SGD","LU0949170772.SGD","LU1150488135.SGD","LU1023059063.AUD","LU0792757196.USD","LU1078025761.USD","LU0072461881.USD","BK4533","BK4558","LU0048578792.EUR","LU0661504455.SGD","LU1015430645.USD","LU1244550577.SGD","LU2242652126.USD","LU1066053197.SGD","LU1400636491.USD","BK4113","LU0237698245.USD","BK4177","IE00B3PB1722.GBP","LU0211331839.USD","LU0868494617.USD","LU1051770623.HKD","SG9999003800.SGD","BK4588","IE00BVYPNT70.USD","LU0550127509.SGD","LU0130517989.USD","BK4183","BK4535","GB00B4LPDJ14.GBP","LU1267930573.SGD","SG9999001176.SGD","LU0006061336.USD","BK4568","LU0234572021.USD","LU0070302665.USD","LU2089283258.USD","LU2211817866.USD","IE0034235071.USD","LU1162221912.USD","IE00BN8TJ469.HKD","LU1267930227.SGD","LU0251142724.SGD","LU2271345857.HKD","LU1894683264.USD","BK4505","LU0506197887.SGD","LU2114397693.USD","IE00B42XCP33.USD","LU1894683348.USD","LU1267930813.SGD","LU1481011671.HKD","LU0320765646.SGD","IE0002270589.USD","BK4597","LU0122379950.USD","LU0477156953.USD","LU1487256676.USD","LU0985320562.USD","BK4212","IE000M9KFDE8.USD","LU0731783048.USD","LU0068578508.USD","LU0052756011.USD","LU0128525689.USD","LU1645745479.HKD","LU0997586432.USD","LU2111349929.HKD","LU3187612489.SGD","LU0225284248.USD","UL","LU0098860793.USD","BK5127","BK4018","BK4550","LU2091194634.USD","LU0742534661.SGD","SG9999002232.USD","SG9999001176.USD","LU0158827948.USD","IE00BGHQF631.EUR","IE00BVYPNS63.GBP","LU1066051498.USD","LU1302929846.USD","LU1057294990.SGD","LU1920062954.HKD","BK4559","LU1019632923.USD","LU1585245621.USD","LU2491049909.HKD","IE00B3T34201.USD","BK4581","LU2108987350.USD","BK4532","LU0971552830.HKD","LU0557290698.USD","LU1153584641.USD","LU1430594728.SGD","IE00BJTD4N35.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0306807586.USD","IE00BMCWC346.EUR","LU0345770993.USD","LU1863844665.USD","LU1883839398.USD","LU1119994140.HKD","BK4592","LU0878866978.SGD","LU0456855351.SGD","IE00BGHQDW50.EUR","LU1019634622.SGD","SG9999011175.SGD","LU2242646235.USD","LU0029864427.USD","LU2028103732.USD","IE00BFXG1179.USD","LU0158827781.USD","BK4007","LU0985481810.HKD","IE00BBT3K403.USD","LU1150488218.USD","LU0742537680.HKD","LU1481011911.USD","LU2023251221.USD","LU1989763690.USD","LU1920063259.USD","LU0162691827.USD","LU1481599808.USD","MKC","LU1003076772.USD","LU0321505868.SGD","LU2275660780.HKD","LU1202635105.USD","LU2401740654.USD","LU0433182093.SGD","LU0127657111.USD","LU0306806265.USD","BK4534","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2620639226","title":"外资再加码!医药巨头阿斯利康核药生产供应基地落子黄埔","url":"https://stock-news.laohu8.com/highlight/detail?id=2620639226","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620639226?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 21:36","pubTimestamp":1773927412,"startTime":"0","endTime":"0","summary":"3月19日,阿斯利康与广州经济技术开发区管理委员会正式签署战略合作框架协议,宣布将在广州开发区、黄埔区建设放射性偶联药物(RDC)生产供应基地。这是阿斯利康今年1月宣布系列投资中的重要一环,标志着这家全球生物医药巨头在核药这一前沿赛道完成战略布局的关键落子。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603193677730187.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677730187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK4568","159938","09939","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4007","BK1515","LU0320765992.SGD","LU2456880835.USD","LU0889565916.HKD","BK4585","BK4588","LU1829250122.USD","LU2236285917.USD","LU0289739699.SGD","LU0109394709.USD","LU0058720904.USD","AZN","BK1161"],"gpt_icon":0},{"id":"2620225813","title":"吉利德科学(GILD.US)CD19/CD20 CAR-T细胞疗法启动III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225813?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 21:12","pubTimestamp":1773925932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月18日,美国临床试验收录网站显示,吉利德科学旗下公司Kite Pharma启动了KITE-753的首个III期临床试验。KITE-753是一款靶向CD19和CD20的双顺反子自体CAR-T细胞疗法。研究的主要终点是第6个月实现完全缓解的患者比例和36个月内的无事件生存期。结果显示,剂量3队列,在14例未接受过CAR-T细胞疗法治疗的患者中,11例实现CR,CR率为79%;总人群,在20例未接受过CAR-T细胞疗法治疗的患者中,14例实现CR,CR率为70%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2089984988.USD","LU1571399168.USD","LU1674673691.USD","GILD","LU1037948897.HKD","SG9999015986.USD","LU0965508806.USD","LU0965509010.AUD","SG9999015978.USD","LU0823416689.USD","LU0965509101.SGD","LU1061106388.HKD","LU0889565916.HKD","BK4568","LU1066051498.USD","LU0289739699.SGD","BK4139","LU1585245621.USD","IE00B3T34201.USD","LU0109394709.USD","LU1839511570.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","SG9999015952.SGD","BK4588","LU0114720955.EUR","III","LU0058720904.USD","LU0234570918.USD","LU1066053197.SGD","IE0002270589.USD","LU1934455863.HKD","LU1037948541.HKD","IE00B19Z3581.USD","LU2112291526.USD","LU0882574055.USD","BK4583","LU1674673428.USD","LU0861579265.USD","LU0965509283.SGD","LU1430594728.SGD","IE00BKVL7J92.USD","CAR","BK4134","LU1023059063.AUD","BK4022","BK4532"],"gpt_icon":0},{"id":"2620003241","title":"阿斯利康将于广州建设放射性偶联药物生产供应基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2620003241","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620003241?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 19:01","pubTimestamp":1773918091,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AZN","LU0058720904.USD","LU1829250122.USD","LU2462157665.USD","LU0289739699.SGD","LU2236285917.USD","IE00B3T34201.USD","LU2417539215.USD","LU0889565916.HKD","BK4568","LU0320765992.SGD","BK4007","LU2456880835.USD","BK4585","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"1115629984","title":"辉瑞:Talzenna联合Xtandi安全性符合各自已知安全特征,未发现新安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1115629984","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115629984?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 18:48","pubTimestamp":1773917316,"startTime":"0","endTime":"0","summary":"辉瑞公司公布的数据显示,Talzenna与Xtandi联合用药的安全性特征与两种药物各自已知的安全性数据保持一致,研究期间未出现新的安全性信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BK4550","LU1066053197.SGD","SG9999003800.SGD","LU1066051498.USD","BK4585","SG9999011175.SGD","LU0985481810.HKD","LU1023059063.AUD","IE00B19Z3581.USD","LU0456855351.SGD","LU0868494617.USD","BK4007","LU1894683348.USD","LU1894683264.USD","IE000M9KFDE8.USD","PFE","IE0002270589.USD","LU0306807586.USD","LU0170899867.USD","SG9999002232.USD","BK4581","LU0289739699.SGD","SG9999002224.SGD","LU0225284248.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4588","LU1057294990.SGD","LU0122379950.USD","SGXZ57979304.SGD","BK4592","BK4599","BK4568","LU0225771236.USD","LU0234572021.USD","LU1883839398.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","BK4534","IE00BLSP4239.USD","SG9999013999.USD","LU0058720904.USD","BK4533"],"gpt_icon":0},{"id":"1111610205","title":"Talzenna联合Xtandi显著改善转移性前列腺癌患者的影像学无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1111610205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111610205?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 18:46","pubTimestamp":1773917215,"startTime":"0","endTime":"0","summary":"一项最新研究显示,将Talzenna与Xtandi联合使用,可显著提升转移性前列腺癌患者的影像学无进展生存期。这一积极结果有望为晚期前列腺癌的治疗提供新的有效方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999003800.SGD","LU0234572021.USD","LU0058720904.USD","SG9999002232.USD","SG9999002224.SGD","BK4007","IE00BBT3K403.USD","LU0225284248.USD","LU0985481810.HKD","LU0122379950.USD","LU1066051498.USD","LU1066053197.SGD","BK4534","IE00BLSP4452.SGD","BK4533","SG9999001176.USD","LU0306806265.USD","BK4581","LU0289739699.SGD","SG9999013999.USD","BK4550","LU0170899867.USD","LU0868494617.USD","AZN","BK4568","BK4585","LU0456855351.SGD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","LU0321505439.SGD","BK4599","LU1057294990.SGD","SG9999001176.SGD","BK4588","LU1894683264.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0225771236.USD","SGXZ57979304.SGD","PFE","LU1883839398.USD","LU1894683348.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2620021540","title":"落子上海细胞治疗全链条,阿斯利康“深耕中国”迈入新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2620021540","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620021540?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 12:52","pubTimestamp":1773895925,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛上海报道在英国首相斯塔默访华带来中英经贸暖风的两个月后,英国制药巨头阿斯利康用实际行动为这一轮双边合作添上了浓墨重彩的一笔。3月19日,阿斯利康正式宣布了一项具有里程碑意义的布局:计划在上海建立细胞疗法商业化生产供应基地与创新中心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603193677171431.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677171431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","LU1829250122.USD","AZN","LU0289739699.SGD","LU2236285917.USD","LU2462157665.USD","BK4585","LU2456880835.USD","BK4007","LU0058720904.USD","IE00B3T34201.USD","BK4568","LU2417539215.USD"],"gpt_icon":0},{"id":"2620290003","title":"阿斯利康宣布在上海建立细胞疗法商业化生产供应基地与创新中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2620290003","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620290003?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 10:54","pubTimestamp":1773888854,"startTime":"0","endTime":"0","summary":"南方财经3月19日电,阿斯利康今日宣布,计划在上海建立细胞疗法商业化生产供应基地与创新中心,将成为首家在中国拥有端到端细胞治疗能力的全球领先生物制药企业。同日,公司与上海市科学技术委员会及英国领先科研与金融机构签署多方合作谅解备忘录。据悉,阿斯利康将在上海自贸区临港新片区建设专门的细胞疗法商业化生产供应基地,用于在中国及其他亚洲市场商业化生产及供应自体CAR-T细胞疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677128937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B3T34201.USD","LU0109394709.USD","LU2236285917.USD","BK4568","LU2462157665.USD","LU2417539215.USD","LU1829250122.USD","LU2456880835.USD","BK4585","BK4588","LU0058720904.USD","LU0320765992.SGD","AZN","LU0889565916.HKD","LU0289739699.SGD","BK4007"],"gpt_icon":0},{"id":"2620297573","title":"阿斯利康中国区副总裁黄彬突然离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2620297573","media":"消费日报财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620297573?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 09:59","pubTimestamp":1773885577,"startTime":"0","endTime":"0","summary":"3月18日,阿斯利康中国方面向记者确认,公司资深高管、阿斯利康中国副总裁、市场准入部门负责人黄彬正式离任。该人士为阿斯利康任职超20年的元老级高管,主导中国市场准入核心业务。截至记者发稿,黄彬本人暂未对外披露后续职业安排。公开资料显示,黄彬,1967年生,中国国籍,无境外永久居留权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677031788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B3T34201.USD","LU0289739699.SGD","LU0320765992.SGD","LU2462157665.USD","BK4568","LU0058720904.USD","AZN","LU0889565916.HKD","BK4007","LU1829250122.USD","LU2456880835.USD","LU2236285917.USD","LU0109394709.USD","LU2417539215.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2620292921","title":"再迎阿斯利康重磅布局!浦东生物医药产业究竟有啥“磁场效应”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620292921","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620292921?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 09:34","pubTimestamp":1773884072,"startTime":"0","endTime":"0","summary":"3月19日,张江科学城再添全球生物医药产业重磅布局——阿斯利康正式宣布在此建设细胞疗法创新中心。这个覆盖早期研究、病毒载体开发、临床生产及注册支持的全链条创新平台,将成为阿斯利康全球细胞疗法版图的关键枢纽,标志着中国在全球下一代细胞治疗领域的创新地位再获提升。生物医药产业是上海三大先导产业之一,也是新一轮科技革命和竞争的焦点赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://biz.eastmoney.com/a/202603193676916419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4568","399441","LU1829250122.USD","LU2456880835.USD","XBI","LU0889565916.HKD","BK4581","BK4007","LU0289739699.SGD","LU0320765992.SGD","LU2462157665.USD","161726","BK4588","AZN","LU2417539215.USD","BK4585","LU2236285917.USD","IE00B3T34201.USD","LU0109394709.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2620266216","title":"分析-TrumpRx 列出的许多药品价格高于在英国支付的价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266216","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620266216?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 02:18","pubTimestamp":1773857895,"startTime":"0","endTime":"0","summary":"分析-TrumpRx 列出的许多药品价格高于在英国支付的价格TrumpRx 上约三分之一药品的英国价格**较低**TrumpRx 大幅降低肥胖症和生育药物的价格白宫达成协议后,制药商看到了对销售和利润的**喜忧参半的**影响 Bhanvi Satija/Michael Erman. 减肥药价格大幅下降路透评估了英国政府为每种处方药支付给药店的费用,以及目前参与的八家公司在 TrumpRx 上列出的价格。该公司称,TrumpRx提供了三种美国生育药物上市价格的84%折扣,这些药物通常在体外受精方案中一起使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4T4061O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ31699556.SGD","LU0942090050.USD","LU0971552673.USD","SG9999013999.USD","LU0310799852.SGD","LU0827474353.SGD","LU1098665638.USD","LU2896262040.SGD","LU1084165304.USD","LU0069063385.USD","IE00BVYPNW00.USD","LU0170899867.USD","LU0553294199.USD","LU0648001328.SGD","LU0784385170.HKD","LLII","LU0823416689.USD","LU1291159041.SGD","IE00B19Z9P08.USD","LU1868836757.USD","IE0001KFT4U8.USD","LU1127390331.HKD","LU0011850046.USD","LU1309081286.SGD","LU1046234339.USD","LU0757432116.USD","SG9999002224.SGD","LU2106854487.HKD","LU0234570918.USD","LU0969580561.USD","LU1571399168.USD","LU0353189680.USD","LU1934455277.USD","IE00BVYPNV92.GBP","LU0058720904.USD","LU0203202063.USD","LU0345777147.USD","BK4585","LU1093756325.SGD","LU0266013472.USD","LU0310800379.SGD","IE00BDGV0183.EUR","IE0005OL40V9.USD","LU2129689605.HKD","LU1078025761.USD","LU0661504455.SGD","LU1196500208.SGD","LU1066053197.SGD","IE00BJLML261.HKD","SG9999003800.SGD","IE00BKPKM643.USD","BK4578","LU2361044865.SGD","LU0130517989.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","BK4568","LU1228905037.USD","LU2087621335.USD","LU2746668974.SGD","SG9999018857.SGD","LU1035773651.USD","LU1934455863.HKD","IE0034235071.USD","LU2237443549.SGD","LU1267930227.SGD","IE00BZ1G4Q59.USD","LU1170363599.USD","LU2271345857.HKD","LU1917777945.USD","LU0511384066.AUD","LU1066051811.HKD","LU0203345920.USD","LU0114720955.EUR","LU2552382058.USD","LU0920840948.USD","IE00BFSS7M15.SGD","LU0820561909.HKD","LU1267930813.SGD","LU0320765646.SGD","LU2168563687.JPY","LU1487256676.USD","IE00BK4W5M84.HKD","LU1941712264.USD","LU0795875086.SGD","BK5011","LU0128525689.USD","LU2111349929.HKD","LU0109391861.USD","LU0225284248.USD","IE00BFSS8Q28.SGD","LU1116320737.USD","LU2091194634.USD","SG9999001176.USD","LU2023250843.SGD","LU2023250504.SGD","LU0211326839.USD","LU0957799991.USD","LU1057294990.SGD","LU2746668461.USD","IE0004445015.USD","LU1153584641.USD","BK4532","LU0557290698.USD","LU1064131342.USD","LU1064927863.SGD","LU0306807586.USD","LU2462157665.USD","LU0861579265.USD","LU0171293334.USD","LU0265550946.USD","LU2750360641.GBP","IE00BFXG1179.USD","LU1720051108.HKD","BK4007","LU0960981461.USD","LU1974910355.USD","LU1104425308.USD","LU1732799900.SGD","LU2125909247.SGD","LU1003076772.USD","LU1551013425.SGD","LU0526926950.USD","IE00BFTCPJ56.SGD","LU1032955483.USD","LU0882574055.USD","LU0640478417.SGD","LU0820561818.USD","LU0306806265.USD","LU2023250330.USD","LU0070217475.USD","LU0784384876.USD","IE00B19Z3581.USD","LU2505996681.GBP","LU0889565080.SGD","LU1244550221.USD","LU0683600562.USD","PFE","SG9999014898.SGD","IE00BLSP4239.USD","LU2237443978.SGD","SG9999001440.SGD","LU1868836914.USD","LU1880407132.USD","LU1941712348.USD","LU0047473722.SGD","LU1699723380.USD","LU0128525929.USD","LU1201861249.SGD","BK4516","LU0109981661.USD","SG9999015945.SGD","LU0965508806.USD","LU0787776722.HKD","LU1037948541.HKD","LU0345777659.USD","SGXZ51526630.SGD","BK4566","LU0390134368.USD","LU0289739699.SGD","LU2264538146.SGD","LU0964806797.USD","LU1280957306.USD","SG9999015358.SGD","IE0034235303.USD","LU0545039389.USD","LU2089984988.USD","GB00BDT5M118.USD","SG9999014880.SGD","LU1323610961.USD","LU0208291251.USD","LU0889566641.SGD","LU0949170772.SGD","LU0792757196.USD","LU1015430645.USD","LU1674673691.USD","LU1051770623.HKD","LU2237438978.USD","LU1496350171.SGD","LU1988902786.USD","LU2125154935.USD","LU1228905540.USD","LU1232071149.USD","LU0784383803.USD","LU0096364046.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU2089283258.USD","IE00BN8TJ469.HKD","LU1035777561.USD","LU2168564149.EUR","LU1868837136.USD","SG9999014542.SGD","LU2417539215.USD","LU1301847155.USD","LU2114397693.USD","IE00B42XCP33.USD","LU0265550359.USD","LU0345769631.USD","LU0985320562.USD","LU0211328371.USD","LU1839511570.USD","LU0052756011.USD","LU0106261372.USD","LU0098860793.USD","LU1623119135.USD","BK4550","IE00BGHQF631.EUR","LU1302929846.USD","LU1880407215.USD","LU2430703251.USD","LU1585245621.USD","LU2756315318.SGD","GSK","BK4581","LU0971552830.HKD","LU0472753341.HKD","BK4139","IE00B19Z3B42.SGD","IE00BKDWB100.SGD","IE00BLSP4452.SGD","LU1732800096.USD","IE00B775H168.HKD","LU2028103732.USD","LU0158827781.USD","LU0985481810.HKD","IE00BBT3K403.USD","SG9999018865.SGD","LU0323591593.USD","LU0965509283.SGD","LU1629891620.HKD","LU1914381329.SGD","LU0079474960.USD","LU2063271972.USD","BK4534","LU2471134879.HKD","IE00BKPKM429.USD","LU2360106947.USD","LU0965509101.SGD","LU0949170426.SGD","LU1496350502.SGD","LU1989772840.SGD","IE00BQJZX424.USD","LU0354030511.USD","LU2168564495.EUR","LU0417517546.SGD","LU2471134952.CNY","IE00BWXC8680.SGD","LU1037948897.HKD","LU0496365809.HKD","LU0345770308.USD","LU2552382132.HKD","LU2552382215.SGD","LU1670756490.USD","LU1506573853.SGD","IE00B7KXQ091.USD","LU1548497426.USD","BK4504","LU2087625088.SGD","IE00B1BXHZ80.USD","LU2279689827.SGD","LU2491050154.USD","LU0920783379.SGD","LU1481600234.SGD","LU2211815571.USD","LU2213496289.HKD","03165","LU1069347547.HKD","SG9999014906.USD","LU0320765489.SGD","LU1989771016.USD","IE00BJJMRY28.SGD","LU0310800965.SGD","LU0471298694.HKD","BK4599","ELIS","LU0130102774.USD","SG9999015952.SGD","LU0354030438.USD","LU1046248800.SGD","LU0432979614.USD","LU1929549753.HKD","LU2471134796.USD","LU1153585028.USD","LU2089284900.SGD","LU0784385840.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU1003077747.HKD","LU1267930730.SGD","LU0823399737.USD","LU2505996509.AUD","LU0320765059.SGD","LU2433249047.HKD","LU0965509010.AUD","LU1023059063.AUD","BK4533","LU0256863811.USD","LU1923622614.USD","LU1244550577.SGD","LU0882574139.USD","LU1061106388.HKD","LU0689626769.HKD","IE00B3PB1722.GBP","LU0211331839.USD","LU0868494617.USD","LU2360032135.SGD","LU2237443382.USD","LU0868494708.USD","LU1718418525.SGD","AZN","LU1267930573.SGD","LU1267930490.SGD","LU1366192091.USD","LU0070302665.USD","LU0353189763.USD","LU1145028129.USD","LU0097036916.USD","LU2125909593.SGD","LU0061475181.USD","LU1894683264.USD","LU0203347892.USD","LU1035775433.USD","LU0256863902.USD","NVO","LU1674673428.USD","ELIL","LU1032466523.USD","LU1894683348.USD","IE0002270589.USD","LU0122379950.USD","LU0477156953.USD","LU1868836591.USD","LU2468319806.SGD","LU1069344957.HKD","LU2592432038.USD","IE000M9KFDE8.USD","LU1935042991.SGD","LU0997586432.USD","SG9999015341.SGD","LU2347655156.SGD","LU0857590862.USD","LU0320765992.SGD","LU1221951046.USD","LU0203201768.USD","LU0689472784.USD","IE0004445239.USD","LU2491049909.HKD","LU1019632923.USD","LU0077335932.USD","IE00B3T34201.USD","LU2108987350.USD","LU0109394709.USD","IE0002141913.USD","LLY","SG9999014559.SGD","LU0963555726.SGD","LU0211327993.USD","LU1019634622.SGD","LU2361044949.HKD","LU1261432733.SGD","LU0029864427.USD","LU1712237335.SGD","LU0823434583.USD","IE00B7SZLL34.SGD","LU2023251221.USD","LU1481599808.USD","LU1059921491.USD","LU2430703178.SGD","LU0912757837.SGD","SG9999015978.USD","LU1202635105.USD","LU2750360997.AUD","LU0006306889.USD","LU0466842654.USD","LU1074936037.SGD","LU0887340254.USD","IE00B4JS1V06.HKD","LU2756315664.SGD","LU0672654240.SGD","LU1093756168.USD","LU0047473722.EUR","LU1551013342.USD","LU2129689514.USD","LU2168564222.USD","LLYX","SG9999014575.USD","IE0009355771.USD","LU2602419157.SGD","LU1814569148.SGD","LU1244550494.USD","IE00B1XK9C88.USD","SG9999014567.USD","LU0708995401.HKD","LU1934455194.USD","BK4583","LU0499090636.EUR","LU2539964713.USD","LU0471298777.SGD","LU2456880835.USD","LU1400636657.SGD","IE0034235188.USD","LU0345769128.USD","LU0738911758.USD","LU0238689110.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","LU0786609619.USD","LU0976567544.SGD","LU2357305700.SGD","LU0980610538.SGD","LU0211326755.USD","LU0708994859.HKD","LU1400636574.HKD","LU0321505439.SGD","LU0289961442.SGD","LU2491050071.SGD","LU2430703095.HKD","LU0289739343.SGD","LU0640476718.USD","LU0575583348.USD","IE00BJT1NW94.SGD","LU0545562505.USD","LU1778281490.HKD","LU1116320901.HKD","LU0385154629.USD","LU1400636491.USD","IE00B19Z9Z06.USD","IE00BWDBJ516.SGD","SG9999015986.USD","LU1804176565.USD","LU0225283273.USD","BK4588","LU0964807845.USD","LU0972486137.USD","LU2471134523.USD","LU2168564065.EUR","LU0889565916.HKD","LU0057025933.USD","LU0795875169.SGD","LLYZ","LU1162221912.USD","SGXZ99366536.SGD","IE00BK4W5L77.USD","LU0161305163.EUR","LU2324357040.USD","LU1119994496.HKD","LU2461242641.AUD","LU1645745479.HKD","LU2293690249.USD","IE00BKVL7J92.USD","LU1989772923.USD","SG9999002232.USD","LU2265009873.SGD","LU0158827948.USD","LU1066051498.USD","BK4559","LU0210536198.USD","SG9999014914.USD","LU2237443895.HKD","LU2237443465.HKD","LU1221951129.SGD","LU1430594728.SGD","LU1868837300.USD","LU0225771236.USD","LU1066051225.USD","LU1983299246.USD","LU0124676726.USD","LU1883839398.USD","IE00B894F039.SGD","BK4592","SG9999017495.SGD","LU0456855351.SGD","LU2129689431.USD","LU2236285917.USD","LU1720051017.SGD","SG9999011175.SGD","LU0820562030.AUD","LU0316494557.USD","LU2361045086.USD","LU0321505868.SGD","IE00BJJMRX11.SGD","LU0823434740.USD","LU0094547139.USD","LU0943347566.SGD","LU2133065610.SGD","SGXZ81514606.USD","LU0198837287.USD","LU2293690082.USD","LU0345770993.USD","IE00BN29S564.USD","LU2237443622.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2620656257","title":"BUZZ-艾伯维下跌,因强生银屑病药物增加竞争风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2620656257","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620656257?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 22:55","pubTimestamp":1773845721,"startTime":"0","endTime":"0","summary":"BUZZ-艾伯维下跌,因强生银屑病药物增加竞争风险3月18日 - ** 制药商艾伯维ABBV.N股价早盘下跌3.3%至212.67美元 ** 法国巴黎银行维持艾伯维 \"中性 \"评级,目标价为213美元** 券商称,J&J获得FDA批准的每日一次口服银屑病药物Icotyde可能与艾伯维的Skyrizi形成竞争,而Skyrizi是艾伯维增长的主要动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4S4061EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU0553294199.USD","LU1037948897.HKD","LU0069063385.USD","BK4534","BK4568","LU1074936037.SGD","SG9999015978.USD","LU0345770308.USD","IE00BVYPNV92.GBP","JNJ","LU0787776722.HKD","LU1430594728.SGD","LU1934455194.USD","LU1934455863.HKD","LU0345769631.USD","LU1059921491.USD","LU0289739343.SGD","LU0256863811.USD","IE000M9KFDE8.USD","ABBV","IE00B3PB1722.GBP","LU2468319806.SGD","IE00BFXG1179.USD","SG9999015945.SGD","LU1894683264.USD","LU0234570918.USD","LU1914381329.SGD","LU1732800096.USD","BK4533","LU0158827948.USD","LU2430703251.USD","LU2471134952.CNY","LU0170899867.USD","LU0640476718.USD","LU0912757837.SGD","LU2237443382.USD","BK4532","LU0738911758.USD","LU0965509283.SGD","BK4581","LU1551013425.SGD","LU1057294990.SGD","LU1989772840.SGD","LU1221951046.USD","LU0124676726.USD","LU1244550221.USD","LU0882574055.USD","LU1894683348.USD","BK4504"],"gpt_icon":0},{"id":"2620259472","title":"强生治疗银屑病的口服药物获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620259472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620259472?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 21:22","pubTimestamp":1773840123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B3PB1722.GBP","LU0234572021.USD","LU0122379950.USD","LU2129689605.HKD","LU0098860793.USD","IE00B2B36J28.USD","LU0792757196.USD","BK4581","LU1032955483.USD","LU2750360641.GBP","LU0912757837.SGD","LU2129689514.USD","LU2468319806.SGD","JNJ","IE00BVYPNV92.GBP","LU0114720955.EUR","BK4007","IE00B3T34201.USD","LABU","IE00B42XCP33.USD","LU0203347892.USD","IE00B1BXHZ80.USD","IE00BLSP4239.USD","IE00BSNM7G36.USD","LU1496350502.SGD","IE000M9KFDE8.USD","LU1066051811.HKD","LU2430703095.HKD","LU2112291526.USD","IE00BGHQF631.EUR","LU2133065610.SGD","LU0203345920.USD","LU0689626769.HKD","LU1267930813.SGD","LU2592432038.USD","LU1894683348.USD","LU2347655156.SGD","BK4592","LU1244550494.USD","BK4568","IE0002270589.USD","LU1221951129.SGD","LU2471134523.USD","LU0795875169.SGD","LU1074936037.SGD","LU1066051498.USD","BK4533","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4559"],"gpt_icon":0},{"id":"2620241259","title":"辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2620241259","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620241259?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 21:21","pubTimestamp":1773840109,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,辉瑞3月18日宣布,其2期FOURLIGHT-1研究达到主要终点。该积极结果支持辉瑞推进atirmociclib在一线治疗及早期疾病中的开发策略,在这些人群中,实现更持久的内分泌治疗疾病控制,有望带来更大的临床获益。Atirmociclib是一种在研、潜在“first-in-class”的口服CDK4抑制剂。该药物由辉瑞发现,目前正用于开发治疗HR阳性、HER2阴性乳腺癌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1066053197.SGD","LU1023059063.AUD","LU0058720904.USD","IE000M9KFDE8.USD","LU0306806265.USD","BK4599","BK4550","SG9999011175.SGD","LU1894683348.USD","SGXZ57979304.SGD","PFE","IE0002270589.USD","LU1894683264.USD","BK4581","IE00BLSP4452.SGD","LU0321505868.SGD","BK4592","BK4007","LU0225771236.USD","SG9999013999.USD","SG9999002224.SGD","SG9999002232.USD","LU1057294990.SGD","SG9999003800.SGD","BK4534","LU0456855351.SGD","LU0306807586.USD","SG9999001176.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1066051498.USD","BK4568","LU0122379950.USD","LU0985481810.HKD","LU0234572021.USD","LU0170899867.USD","LU0868494617.USD","BK4533","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU1883839398.USD","BK4585","LU0321505439.SGD","LU0225284248.USD","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}